Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
CareDx, Inc. logo — Creating life-changing solutions that enable transplant pati...

CareDx, Inc.

Creating life-changing solutions that enable transplant patients to thrive.

Founded 1998 United States Brisbane, United States 812 employees Post-IPO Equity Total: $508.64M Biotechnology, Health Care +1

General Information

Company Name CareDx, Inc.
Founded Year 1998
Location United States Brisbane, United States
Employees 812
Industries Biotechnology, Health Care, Information Technology
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with CareDx, Inc.. To contact CareDx, Inc., visit caredx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does CareDx, Inc. compare?

A PDF of CareDx, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting CareDx, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About CareDx, Inc.

CareDx, Inc. is a biotechnology company dedicated to revolutionizing transplant patient care through innovative surveillance management solutions. Their focus on non-invasive diagnostics, leveraging genomics and bioinformatics technology along with robust clinical evidence, positions them as a leader in organ transplant surveillance and pre-transplant HLA typing solutions. One of their pioneering offerings is AlloSure, a non-invasive blood test that measures allograft injury and identifies the probability of active rejection in kidney transplant patients. This proprietary Next-Generation Sequencing (NGS) based test is analytically validated and outperforms traditional methods like serum creatinine, demonstrating high accuracy and precision in detecting active rejection. Additionally, CareDx provides AlloMap Molecular Expression Testing for heart transplant recipients, aiding in the identification of patients with stable allograft function and low probability of acute cellular rejection. This testing, available since 2005, has received clearances and marks from regulatory bodies and is integrated into international guidelines for heart transplant patient care. Founded in 1998 and headquartered in the United States, the company attracted a $164.00M Post-IPO Equity investment in January 2021, indicating strong investor confidence in their innovative solutions for improving transplant patient outcomes. CareDx's commitment to leveraging advanced technology to address critical needs in transplant patient care positions them as a key player in the intersection of biotechnology, healthcare, and information technology.

Business keywords: organ transplant, transplant patients, genomics technology, bioinformatics technology, clinical evidence, surveillance solutions, HLA typing solutions, Next-Generation Sequencing, organ injury, donor-derived cell-free DNA, kidney transplant recipients, heart transplant recipients, AlloMap Molecular Expression Testing, non-invasive diagnostics, transplant patient care

Funding Rounds & Investors (15)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $164.00M -
21 Jan 2021
Post IPO Equity $117.10M -
09 Jun 2020
Post IPO Equity $52.80M -
13 Nov 2018
Post IPO Equity $18.30M -
05 Oct 2017
Post IPO Debt $25.00M -
15 Mar 2017
Post IPO Equity $22.17M -
17 Jun 2016
Post IPO Equity $14.17M -
04 Apr 2016
Debt Financing $20.00M 1
Armentum Partners
Armentum Partners
01 Jan 2015
Debt Financing $15.00M 2
Silicon Valley Bank, Oxford Finance LLC
12 Sep 2012
Debt Financing $2.16M -
14 Nov 2011

View All 15 Funding Rounds

CareDx, Inc. Alternatives & Competitors

View All Alternatives
CareDx, Inc. vs
GeneCast Biotechnology Co., Ltd.
GeneCast Biotechnology Co., Ltd. China

Founded in November, 2014, Genecast (Beijing) Biotechnology Co. is located in HealthWork (Beijing) I...

Series E
21 employees
Biotechnology, Health Care
Compare CareDx, Inc. vs GeneCast Biotechnology Co., Ltd.
CareDx, Inc. vs
Sutro Biopharma, Inc.
Sutro Biopharma, Inc. United States

Changing the future of Oncology

IPO
208 employees
Biotechnology, Information Technology
Compare CareDx, Inc. vs Sutro Biopharma, Inc.
CareDx, Inc. vs
ACELYRIN, INC.
ACELYRIN, INC. United States

We are a late-stage clinical biopharma company focused on providing life-changing new treatment opti...

Acquired
103 employees
Biopharma, Biotechnology
View all alternatives

FAQ About CareDx, Inc.

Creating life-changing solutions that enable transplant patients to thrive.
CareDx, Inc. was founded in 1998.
CareDx, Inc. is headquartered in Brisbane, United States.
CareDx, Inc. operates in Biotechnology, Health Care and Information Technology. Its work centres on organ transplant, transplant patients, genomics technology and bioinformatics technology.
CareDx, Inc. has approximately 812 employees.
CareDx, Inc. has completed 15 funding rounds, raising a total of $508.64M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to CareDx, Inc. include GeneCast Biotechnology Co., Ltd., Sutro Biopharma, Inc., ACELYRIN, INC., Theravance Biopharma US, Inc., Sana Biotechnology, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CareDx, Inc. and GeneCast Biotechnology Co., Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CareDx, Inc., https://bouncewatch.com/company/caredx-inc, updated 8 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes